FAIRFIELD, Conn., Aug. 27, 2008 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (AMEX:CTT) announced today the sale of the Flip Chip technology patent portfolio, owned by CTT and other investors, to an Asian-based company. The portfolio consists of a group of U.S. and international patents covering the wafer interconnect process, commonly known as "Flip Chip," because of the manner in which they are mounted to the device for greater efficiency.
Girish Nallur, PhD, CTT's Chief Scientific Officer, said, "The patent portfolio describes methods, devices, systems and manufacturing processes for assembling and testing flip chips with enhanced space and thermal economy. These technologies will provide a significant impetus to the consumer industry for manufacture of miniaturized electronic devices with ever-increasing functionality. Ultimately it is the consumer that benefits."
"CTT's management team is focused on creating value from technologies within our portfolio and restoring stockholder value," said John B. Nano, CTT's Chairman, President and CEO. "We are aggressively marketing the pain management therapy, breast cancer detection test, MC Square stress reduction device (www.relaxmc.com), UAD surgical prosthetics and solar technologies to drive revenue growth, improve profitability and create shareholder value. Our full technology portfolio may be viewed on our website."
About Competitive Technologies, Inc.
Competitive Technologies, established in 1968, is a full service technology transfer and licensing provider focused on the technology needs of its customers and transforming those requirements into commercially viable solutions. CTT is a global leader in identifying, developing and commercializing innovative technologies in life, electronic, nano, and physical sciences developed by universities, companies and inventors. CTT maximizes the value of intellectual assets for the benefit of its customers, clients and shareholders. Visit CTT's website: www.competitivetech.net
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2007, filed with the SEC on October 29, 2007, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.